Member Info for WeTookPelham

Everything has price as they saying goes. You'd think there's a price that Scancell/Redmile would accept at any clinical stage?

"It’s unlikely there will be/have been any serious offers for Scancell without trial data". I've never fully understood this, there have been lots of pre-clinical deals for other small bios for very large sums havent there? What's stopping a deal happening here pre-clinical exactly?

Also RE GSK, i would be very surprised in Scancell are not on the radar of all major pharma who are in the M&A arena for the kind of tech Scancell offer. Lets not forget they are already in cahoots witha major european pharma with the Mabs products.

Wow, is that 10x Affinivax's current market cap?
GSK on a bit of an buying spree of late trying to bolster their portfolio it seems?

Anyone care to email Scancell for clarification?

@Chester18 - I don't think they RNS attendance at conferences very often, and occasionally I think they may have tweeted about it. I may be wrong though. But usually it's someone on here who's done some digging to find out about any attendance?
IMO there is very little consistency about what news is given to shareholders, either through RNS's or twitter.
I can just about put up with the radio silence as long as the (finally) deliver.

No tweets or retweets since 22nd April either, which as mentioned seems to follow a pattern of them going radio silent before the next RNS.
https://twitter.com/scancellpharma

Wasn't the recent one they were at in Boston the "big" conference?

RE no news to report, with Covidity results due, Moditope first patient dosed news due, Glycan partnerships updates (as immediate targets), I very much doubt their is no news to report, just a waiting game IMO.

Part of me hopes/wonders if some kind of partnership/contractual news is incoming hence there very silent radio silence of late?

RE trials, don't forget they are also recruiting for this role:
https://www.scancell.co.uk/senior-clinical-research-associate-oxford

...

Bored! :)

...Buys showing as sells over here on LSE.

Don't forget about Zakari, which incidentally submitted its latest/required documents:
https://find-and-update.company-information.service.gov.uk/company/13408042/filing-history

Great find!

Was that tiny trade of 47 shares enough to bring it down?
I believe we've seen similar price action before many times. But just IMO, I'm just speculating.

What are the odds of that? Can we ask how that came about?
But yes good omen indeed...Definite RNS tomorrow morning then :)

...over on advfn:
"24/5/2022
08:07 hn120: Hi, I have been watching this stock for a little while. Does anyone know if there are any pre-orders for Covidity. Governments around the World pre-ordered the other vaccines in their 10's of millions before they were approved. Would you expect the same to happen here. Just trying to time my buy "

...again. Approx 6-7 weeks since last RNS I think. Has a familiar pattern it seems were they go quiet on twitter, announce an RNS then go on twitter blitz.
So you'd think/hope news soon!?

https://trademarks.justia.com/972/89/glymab-97289101.html

...all day? Unusual, even for sclp?

...of sells, but all closely timed together?